March 5th 2024
The decision was based on clinical studies demonstrating no clinically meaningful differences between the biosimilar and its reference product.
All about osteoporosis: Meeting the treatment challenge
April 29th 2010Following the release of revised National Osteoporosis Foundation guidelines and of the World Health Organization’s fracture risk assessment tool, several pharmacological therapies have become available to help improve outcomes in patients with osteoporosis.